Skip navigation

Pharmaceutical Regulation and Product Liability

21st April 2006

Topics:

  • Recent Developments in US Pharmaceutical Regulation: Update on FDA Physician Labelling Rule
  • The importance of dialogue between regulators
  • 'The changing shape of Pharmaceutical risk'
  • The PREP Act: Liability Protection to Ensure Public Health Protection Against Pandemic Flu
  • Regulation under the scrutiny of the Media
  • The financial impact of pharmaceutical regulation and litigation
  • Obstacles to access to justice in pharmaceutical cases
  • A worldwide Forum?
  • European trends in pharmaceutical litigation
  • US trends in pharmaceutical litigation
  • Liability arising from clinical trials
  • Global regulation of pharmaceuticals: dialogue, efficiency, safety
  • Challenges of a world-wide pharmaceutical law suit

7 CPD hours may be claimed by both solicitors and barristers through attendance at this event.

This event has been kindly sponsored by

4 New Square Logo Lovells

Institute members may access papers from this event by following this link.


27th February 2018 | LONDON

UK-EU Dispute Resolution Post-Brexit: What role for the CJEU?

Read more

28th February 2018 | LONDON

Competition in Financial Services

Read more

8th March 2018 | LONDON

ITF event: General Principles of Law in Investment Arbitration, and the Hierarchy of Norms under International Law

Read more

13th March 2018

Constitutional Recognition of First Nations in Australia

Read more

27th March 2018

The Use of Force in Relation to Sovereignty Disputes over Land Territory

Read more